H.R. 4365/S. 2587 - Department of Defense Appropriations for FY 2024; H.R. 2882 - Further Consolidated Appropriations Act, 2024 and unnumbered House and Senate FY25 Department of Defense Appropriations - issues related to defense technology.
unnumbered House and Senate FY25 Department of Defense Appropriations - issues related to defense technology.
Duration: February 3, 2020
to
present
General Issues: Defense , Budget/Appropriations , Medical/Disease Research/Clinical Labs , Health Issues
Spending: about $380,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2020: U.S. Senate, House of Representatives, Defense - Dept of (DOD), Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC), Office of Science & Technology Policy (OSTP)
Affiliated organizations: Qorvo
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Thomas Hawley
Deputy Under Secretary of the Army; Professional Staff Member, House Armed Services Committee
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Hawley LLC lobbied for MLA Associates on behalf of Clark Street Associates LLC on behalf of Qorvo , earning $20,000. The report was filed on April 17.
Original Filing: 301552588.xml
Lobbying Issues
H.R. 4365/S. 2587 - Department of Defense Appropriations for FY 2024; H.R. 2882 - Further Consolidated Appropriations Act, 2024 and unnumbered House and Senate FY25 Department of Defense Appropriations - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
Lobbying Issues
unnumbered House and Senate FY25 Department of Defense Appropriations - issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, Hawley LLC lobbied for MLA Associates on behalf of Clark Street Associates LLC on behalf of Qorvo , earning $20,000. The report was filed on Jan. 19.
Original Filing: 301532362.xml
Lobbying Issues
Issues related to implementation of the Chips and Science Act of 2022 (P.L. 117-167).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
Lobbying Issues
Department of Defense Appropriations Act for FY 2024 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, Hawley LLC lobbied for MLA Associates on behalf of Clark Street Associates LLC on behalf of Qorvo , earning $20,000. The report was filed on Oct. 16, 2023.
Original Filing: 301501791.xml
Lobbying Issues
Issues related to implementation of the Chips and Science Act of 2022 (P.L. 117-167).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
Lobbying Issues
Department of Defense Appropriations Act for FY 2024 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, Hawley LLC lobbied for MLA Associates on behalf of Clark Street Associates LLC on behalf of Qorvo , earning $20,000. The report was filed on July 16, 2023.
Original Filing: 301477114.xml
Lobbying Issues
Issues related to implementation of the Chips and Science Act of 2022 (P.L. 117-167).
H.R. 2670 - National Defense Authorization Act of 2024 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
1st Quarter, 2023
In Q1, Hawley LLC lobbied for MLA Associates on behalf of Clark Street Associates LLC on behalf of Qorvo , earning $20,000. The report was filed on April 14, 2023.
Original Filing: 301452027.xml
Lobbying Issues
Defense Appropriations Act for FY2024 - issues related to defense technology
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, Hawley LLC lobbied for MLA Associates on behalf of Clark Street Associates LLC on behalf of Qorvo , earning $20,000. The report was filed on Jan. 18, 2023.
Original Filing: 301431733.xml
Lobbying Issues
Issues related to implementation of the Chips and Science Act of 2022 (P.L. 117-167).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
Lobbying Issues
Defense Appropriations Act for FY 2023, concerning issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD)
3rd Quarter, 2022
In Q3, Hawley LLC lobbied for MLA Associates on behalf of Clark Street Associates LLC on behalf of Qorvo , earning $20,000. The report was filed on Oct. 18, 2022.
Original Filing: 301407563.xml
Lobbying Issues
National Defense Authorization Act for FY 2023 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to pathogen testing for COVID 19 and other diseases, including the National Defense Authorization Act for FY2023
Agencies Lobbied
Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
issues related to pathogen testing for COVID and other diseases, including the National Defense Authorization Act for Fiscal Year 2023.
Agencies Lobbied
Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Lobbying Issues
Defense Appropriations Act for FY 2023, concerning issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
Hawley LLC amended a lobbying report for representation of MLA Associates on behalf of Clark Street Associates LLC on behalf of Qorvo in Q22022 on Nov. 12, 2022.
Original Filing: 301422624.xml
Lobbying Issues
National Defense Authorization Act for FY 2022 and National Defense Authorization Act for FY 2023 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to pathogen testing for COVID 19 and other diseases, including the National Defense Authorization Act for FY2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
issues related to pathogen testing for COVID and other diseases, including the National Defense Authorization Act for Fiscal Year 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Lobbying Issues
Defense Appropriations Act for FY 2022 and the Defense Appropriations Act for FY 2023, concerning issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
In Q2, Hawley LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $30,000. The report was filed on July 16, 2022.
Original Filing: 301381731.xml
Lobbying Issues
National Defense Authorization Act for FY 2022 and National Defense Authorization Act for FY 2023 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to pathogen testing for COVID 19 and other diseases, including the National Defense Authorization Act for FY2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
issues related to pathogen testing for COVID and other diseases, including the National Defense Authorization Act for Fiscal Year 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Lobbying Issues
Defense Appropriations Act for FY 2022 and the Defense Appropriations Act for FY 2023, concerning issues related to defense technology.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
Hawley LLC amended a lobbying report for representation of MLA Associates on behalf of Clark Street Associates LLC on behalf of Qorvo in Q12022 on Nov. 12, 2022.
Original Filing: 301422623.xml
Lobbying Issues
National Defense Authorization Act for FY 2022 and National Defense Authorization Act for FY 2023 (not yet introduced) - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to pathogen testing for COVID 19 and other diseases, including the not yet introduced National Defense Authorization Act for FY2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
issues related to pathogen testing for COVID and other diseases, including the not yet introduced National Defense Authorization Act for FY 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Lobbying Issues
HR 4432 Defense Appropriations Act for FY 2022 and the not yet introduced Defense Appropriations Act, concerning issues related to defense technology;
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, Hawley LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $30,000. The report was filed on April 14, 2022.
Original Filing: 301356310.xml
Lobbying Issues
National Defense Authorization Act for FY 2022 and National Defense Authorization Act for FY 2023 (not yet introduced) - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to pathogen testing for COVID 19 and other diseases, including the not yet introduced National Defense Authorization Act for FY2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
issues related to pathogen testing for COVID and other diseases, including the not yet introduced National Defense Authorization Act for FY 2023.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Lobbying Issues
HR 4432 Defense Appropriations Act for FY 2022 and the not yet introduced Defense Appropriations Act, concerning issues related to defense technology;
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2021
In Q4, Hawley LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $30,000. The report was filed on Jan. 11, 2022.
Original Filing: 301321432.xml
Lobbying Issues
National Defense Authorization Act for FY 2022 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to pathogen testing for COVID 19 and other diseases.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
issues related to pathogen testing for COVID and other diseases.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
HR 4432 Defense Appropriations Act for FY 2022 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, Hawley LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $30,000. The report was filed on Oct. 17, 2021.
Original Filing: 301300738.xml
Lobbying Issues
National Defense Authorization Act for FY 2022 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to pathogen testing for COVID 19 and other diseases.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
issues related to pathogen testing for COVID and other diseases.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC)
Lobbying Issues
HR 4432 Defense Appropriations Act for FY 2022 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, Hawley LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $30,000. The report was filed on July 17, 2021.
Original Filing: 301278586.xml
Lobbying Issues
National Defense Authorization Act for FY 2022 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to pathogen testing for COVID 19 and other diseases.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Office of Science & Technology Policy (OSTP) Centers For Disease Control & Prevention (CDC)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
issues related to pathogen testing for COVID and other diseases.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Science & Technology Policy (OSTP)
Lobbying Issues
Defense Appropriations Act for FY 2022 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, Hawley LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $30,000. The report was filed on April 17, 2021.
Original Filing: 301255019.xml
Lobbying Issues
National Defense Authorization Act for FY 2022 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues related to pathogen for COVID 19 and other diseases testing.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Office of Science & Technology Policy (OSTP) Centers For Disease Control & Prevention (CDC)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
issues related to pathogen testing for COVID and other diseases.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Science & Technology Policy (OSTP)
Lobbying Issues
Defense Appropriations Act for FY 2022 - issues related to defense technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2020
In Q4, Hawley LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $30,000. The report was filed on Jan. 12, 2021.
Original Filing: 301230289.xml
Lobbying Issues
Defense microelectronics technology; medical testing technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Lobbying Issues
medical testing technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Office of Science & Technology Policy (OSTP) Centers For Disease Control & Prevention (CDC)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
medical testing technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Centers For Disease Control & Prevention (CDC) Office of Science & Technology Policy (OSTP)
3rd Quarter, 2020
In Q3, Hawley LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $20,000. The report was filed on Oct. 20, 2020.
Original Filing: 301218354.xml
Lobbying Issues
Defense microelectronics technology; medical testing technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Lobbying Issues
medical testing technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives Defense - Dept of (DOD) Health & Human Services - Dept of (HHS)
Type of Issue
Medical/Disease Research/Clinical Labs Health Issues
2nd Quarter, 2020
In Q2, Hawley LLC lobbied for Clark Street Associates LLC on behalf of Qorvo , earning $10,000. The report was filed on July 18, 2020.
Original Filing: 301192773.xml
Lobbying Issues
Defense microelectronics technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2020
Hawley LLC amended a lobbying report for representation of Clark Street Associates LLC on behalf of Qorvo in Q12020 on April 18, 2020.
Original Filing: 301171418.xml
Lobbying Issues
Defense microelectronics technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2020
In Q1, Hawley LLC lobbied for Clark Street Associates LLC on behalf of Qorvo . The report was filed on April 17, 2020.
Original Filing: 301170849.xml
Lobbying Issues
Defense microelectronics technology
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate